Vaccine News and Research

Latest Vaccine News and Research

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Researchers assessed the impact of SARS-CoV-2 infection and severity on coronary and Alzheimer’s disease pathways.

29 Jul 2022

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

Researchers estimated the probability of SARS-CoV-2 reinfection following COVID-19 recovery. Additionally, they determined the effectiveness of the primary vaccination series in reducing the reinfection risk.

29 Jul 2022

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Researchers estimated the impact of different COVID-19 mRNA booster vaccinations in the United States during fall 2022.

29 Jul 2022

Moderna COVID vaccine is more effective in older and sicker veterans over time

Researchers report the higher effectiveness of the Moderna COVID-19 vaccine as compared to the Pfizer COVID-19 vaccine.

28 Jul 2022

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

Researchers describe the evolution of the SARS-CoV-2 non-structural protein 1 (NSP1).

28 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Researchers identify SARS-CoV-2 cross-reactive antibodies in poultry farm workers exposed to the avian infectious bronchitis virus.

28 Jul 2022

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

A study by the Geneva University Hospitals (HUG), the Faculty of Medicine of the University of Geneva and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2, almost three quarters of whom acquired them through an infection.

28 Jul 2022

Study provides a better understanding of accessibility to U.S. drugstores

Almost 90% of the U.S. population lives within 5 miles of a community pharmacy, but more than half of Americans have to commute for more than 1 mile to reach a pharmacist.

28 Jul 2022

Accurate rapid-testing device displays antibody levels in an easily readable way

Vaccines have become the most important weapon in the fight against the COVID-19 pandemic, but antibody levels after vaccination decay quickly over time.

28 Jul 2022

KHN’s ‘What the Health?’: Manchin makes a deal

The Democrats' on-again, off-again budget bill is apparently on again, and it's bigger than expected. In a surprise move, Senate Majority Leader Chuck Schumer announced an agreement with Sen. Joe Manchin (D-W.Va.) to expand the scope of the limited health bill that was headed to the Senate floor to also include climate change and some tax increases for corporations and certain wealthy Americans.

28 Jul 2022

Vaccine News and Research

Latest Vaccine News and Research

Proteomics profiling of COVID-19 patients identifies dysregulated proteins and pathways

Vaccination after COVID-19 recovery reduces reinfection risk by almost 50%

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Moderna COVID vaccine is more effective in older and sicker veterans over time

The global mutation landscape of the SARS-CoV-2 non-structural protein 1

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Cross-reactive SARS-CoV-2 antibodies after exposure to avian coronavirus vaccine

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Study provides a better understanding of accessibility to U.S. drugstores

Accurate rapid-testing device displays antibody levels in an easily readable way

KHN’s ‘What the Health?’: Manchin makes a deal

Weak antibody response yet robust cellular immunity identified in children after SARS-CoV-2 Omicron infection

Comparing SARS-CoV-2 Omicron BA.2 and BA.5 vaccine breakthrough infections

The identification and characterization of an anti-SARS-CoV-2 monoclonal antibody with superior breadth and potency

Does vaccine- or infection-induced immunity protect less well against infection by specific SARS-CoV-2 variants?

The effect of Artemisia annua hot water extracts against the SARS-CoV-2 Omicron variant

COVID-19 Moderna vaccine induces significant antibody reactions among children

Everything you need to know about Paxlovid — especially, should you take it?

World Hepatitis Day 2022: Why Accelerating the Fight Against Hepatitis Cannot Wait

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in